Stay updated on CAR-T for CD33+ AML Clinical Trial
Sign up to get notified when there's something new on the CAR-T for CD33+ AML Clinical Trial page.

Latest updates to the CAR-T for CD33+ AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a dedicated Locations section with Texas as the study site. The HHS Vulnerability Disclosure and the previous 'Texas Locations' entry were removed, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page, with no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedDeleted a general operating status notice about funding-related delays and links to cc.nih.gov and opm.gov for updates.SummaryDifference0.4%

- Check70 days agoChange DetectedNo additions or deletions were detected on the page; the content and structure remain unchanged.SummaryDifference0.4%

- Check98 days agoChange Detected- Added a prominent notice about government funding lapse and current operating status, plus a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed reference to v3.1.0.SummaryDifference3%

- Check105 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.1%

Stay in the know with updates to CAR-T for CD33+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR-T for CD33+ AML Clinical Trial page.